PhRMA Joins with National Minority Quality Forum and Microsoft to Address Diversity in Clinical Trials
Clinical Trials Friday, June 21st, 2013NMQF: June 18, 2013
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that it is partnering with the National Minority Quality Forum (NMQF) and Microsoft to help increase diversity in clinical trials.
“Promoting awareness and creating connectivity that can translate into enhanced participation in clinical trials by a diverse patient population is a priority for PhRMA and our member companies,” stated Dr. Salvatore Alesci, M.D., Ph.D, Vice President of Scientific Affairs at PhRMA. “This collaboration brings clinical research and healthcare closer to each other to prevent disparities in the evaluation and access to innovative medicines.”
The collaboration will include joint outreach efforts as well as support for the creation of the National Clinical Trial Network (NCTN), an interactive portal linking communities of patients, practicing physicians and researchers to increase participation and diversity in clinical trials, which will be introduced in the fourth quarter of 2013. Read more